No headlines found.
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
Globe Newswire (Thu, 28-Mar 7:00 AM ET)
Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The Firm's lead product candidate, avasopasem manganese, is a highly selective small molecule dismutase mimetic for severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. The Firm's second product candidate, rucosopasem manganese, has been in development to augment the anti-cancer efficacy of stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer (NSCLC) and locally advanced pancreatic cancer (LAPC).
Galera Therapeutics trades on the NASDAQ stock market under the symbol GRTX.
As of April 19, 2024, GRTX stock price was flat at $0.18 with 651,963 million shares trading.
GRTX has a beta of 0.04, meaning it tends to be less sensitive to market movements. GRTX has a correlation of 0.00 to the broad based SPY ETF.
GRTX has a market cap of $10.01 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, GRTX stock traded as high as $10.79 and as low as $.09.
The top ETF exchange traded funds that GRTX belongs to (by Net Assets): VXF, IWC.
GRTX has underperformed the market in the last year with a return of -93.3%, while the SPY ETF gained +21.2%. In the last 3 month period, GRTX fell short of the market, returning -2.6%, while SPY returned +4.3%. However, in the most recent 2 weeks GRTX has outperformed the stock market by returning +13.6%, while SPY returned -3.5%.
GRTX support price is $.17 and resistance is $.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRTX stock will trade within this expected range on the day.